Proof-of-concept Studies For A Novel Anti-thrombotic Agent
Funder
National Health and Medical Research Council
Funding Amount
$632,352.00
Summary
Blood clots cause most heart attacks and strokes, and platelets are the blood cells that form these clots. Drugs that block platelet function, such as aspirin, are used to prevent heart attack and stroke but are frequently ineffective. Here, we will develop a new drug that prevents platelet incorporation into blood clots, that will be suitable for the prevention of heart attack and stroke in humans, and that may improve on existing therapies.
A Novel Liver Cancer Therapy Targeting Tumour Stroma
Funder
National Health and Medical Research Council
Funding Amount
$387,902.00
Summary
In Australia, there are 1,300 new cases of liver cancer each year with an average survival of 7 months. Liver cancer is now the most rapidly increasing cancer, probably caused by more hepatitis, obesity and diabetes. Our commercial partner has a novel innovative new antibody that shrinks other cancer types and we want to see how well it combats liver cancer in mice. This antibody has a raft of superior features and we have a clear plan towards making it available to patients.